Rajeev M. Shah, Director, 10% Owner at Vor Biopharma Inc. (VOR), sold 912,563 shares at $30.55 ($26.9M) on 2025-10-15, disclosed to the SEC on 2025-10-17.
Open-market sale of $26.9M VOR by Director, 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $30.55 | 8,384 | $256K | 1.0% |
| 2 | $30.55 | 8,384 | $256K | 1.0% |
| 3 | $30.55 | 42,699 | $1.3M | 4.8% |
| 4 | $30.55 | 42,699 | $1.3M | 4.8% |
| 5 | $31.17 | 46 | $1K | 0.0% |
| 6 | $31.17 | 234 |
| $7K |
| 0.0% |
| 7 | $29.32 | 21,804 | $639K | 2.4% |
| 8 | $29.32 | 21,804 | $639K | 2.4% |
| 9 | $29.32 | 111,041 | $3.3M | 12.1% |
| 10 | $29.32 | 111,041 | $3.3M | 12.1% |
| 11 | $30.36 | 15,826 | $480K | 1.8% |
| 12 | $30.36 | 15,826 | $480K | 1.8% |
| 13 | $30.36 | 3,108 | $94K | 0.4% |
| 14 | $30.36 | 3,108 | $94K | 0.4% |
| 15 | $31.35 | 4 | $125 | 0.0% |
| 16 | $31.35 | 20 | $627 | 0.0% |
| 17 | $29.12 | 174,594 | $5.1M | 18.9% |
| 18 | $29.12 | 174,594 | $5.1M | 18.9% |
| 19 | $29.12 | 34,284 | $998K | 3.7% |
| 20 | $29.12 | 34,284 | $998K | 3.7% |
| 21 | $30.28 | 30,758 | $931K | 3.5% |
| 22 | $30.28 | 30,758 | $931K | 3.5% |
| 23 | $30.28 | 6,040 | $183K | 0.7% |
| 24 | $30.28 | 6,040 | $183K | 0.7% |
| 25 | $31.00 | 2,492 | $77K | 0.3% |
| 26 | $31.00 | 12,691 | $393K | 1.5% |
| Total | $29.52 avg | 912,563 | $26.9M | 100% |
| Filing → |
| AVTE | BUY | 2024-06-20 | $3.1M | — | Filing → |
| HOWL | BUY | 2023-01-10 | $4.1M | — | Filing → |
| IMRA | BUY | 2022-12-12 | $191K | — | Filing → |